Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AVGO stock price vs TXN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TXN's multiple
Needs TXN P/E.
Implied fair value · at AVGO's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Broadcom Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
TEXAS INSTRUMENTS INCORPORATED · implied price per share
Bear
$20.64
Base
$24.46
Bull
$31.23
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe AVGO can sustain its high growth and margin profile long enough to justify a premium far above both its historical band and DCF range, then hold or add; otherwise, reduce exposure because the current price already embeds optimistic assumptions despite only modest P/E separation from TXN.
AVGO’s current price of $392.27 implies a -40.1% downside to the modeled P/E-based value of $234.84, indicating a large valuation gap. Although AVGO trades at roughly the same P/E as TXN, it commands a much richer sales and EBITDA multiple, suggesting the market is paying for superior scale and growth rather than current earnings alone.
Supporting Metrics
